ECM
TECH icon

Everence Capital Management’s Bio-Techne TECH Stock Holding History

Everence Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,350
Closed -$256K – 896
2025
Q4 		$256K Hold
4,350
– – 0.02% 655
2025
Q3 		$242K Hold
4,350
– – 0.01% 696
2025
Q2 		$224K Hold
4,350
– – 0.01% 713
2025
Q1 		$255K Hold
4,350
– – 0.02% 638
2024
Q4 		$313K Sell
4,350
-2,750
-39% -$202K 0.02% 554
2024
Q3 		$568K Hold
7,100
– – 0.04% 386
2024
Q2 		$449 Hold
7,100
– – 0.03% 419
2024
Q1 		$500 Hold
7,100
– – 0.03% 408
2023
Q4 		$548K Sell
7,100
-3,330
-32% -$219K 0.04% 368
2023
Q3 		$710 Buy
+10,430
New +$824K 0.06% 285
2023
Q1 		– Sell
-5,360
Closed -$444 – 789
2022
Q4 		$444 Hold
5,360
– – 0.04% 411
2022
Q3 		$381K Hold
5,360
– – 0.04% 427
2022
Q2 		$464K Hold
5,360
– – 0.04% 363
2022
Q1 		$580K Hold
5,360
– – 0.04% 337
2021
Q4 		$693K Buy
+5,360
New +$657K 0.05% 307

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Everence Capital Management's TECH Position: Q1 2026 in Review

Everence Capital Management sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 4,350 shares — an estimated $256K sold.

Everence Capital Management first reported a position in TECH in Q4 2021 and held it in 15 quarters. The position peaked at $693K in Q4 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Everence Capital Management reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • Everence Capital Management sold 4,350 Bio-Techne shares in Q1 2026, an estimated $256K.
  • Everence Capital Management first reported a position in Bio-Techne in Q4 2021 and held it in 15 quarters.
  • Everence Capital Management's Bio-Techne position peaked at $693K in Q4 2021.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.